AU2001277824A1 - Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation - Google Patents
Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparationInfo
- Publication number
- AU2001277824A1 AU2001277824A1 AU2001277824A AU7782401A AU2001277824A1 AU 2001277824 A1 AU2001277824 A1 AU 2001277824A1 AU 2001277824 A AU2001277824 A AU 2001277824A AU 7782401 A AU7782401 A AU 7782401A AU 2001277824 A1 AU2001277824 A1 AU 2001277824A1
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- immunomoduling
- anticancerogenic
- antibacterial
- antioxidant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2000118424/14A RU2165769C1 (en) | 2000-07-13 | 2000-07-13 | Antibacterial, antioxidant, immunomodulating and anticancer preparation and method of its embodiment |
RU2000118424 | 2000-07-13 | ||
PCT/RU2001/000276 WO2002003910A2 (en) | 2000-07-13 | 2001-07-09 | Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001277824A1 true AU2001277824A1 (en) | 2002-01-21 |
Family
ID=20237690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001277824A Abandoned AU2001277824A1 (en) | 2000-07-13 | 2001-07-09 | Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001277824A1 (en) |
RU (1) | RU2165769C1 (en) |
WO (1) | WO2002003910A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6399570B1 (en) | 1999-02-05 | 2002-06-04 | Agennix, Inc. | Antimicrobial/endotoxin neutralizing polypeptide |
WO2003094952A1 (en) | 2002-05-10 | 2003-11-20 | Agennix Incorporated | Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
SI2298338T1 (en) | 2002-09-16 | 2012-11-30 | Agennix Inc | Lactoferrin compositions and methods of treatment of skin wounds |
AU2003296447A1 (en) | 2002-12-10 | 2004-06-30 | Agennix Incorporated | Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease |
WO2004054608A2 (en) | 2002-12-12 | 2004-07-01 | Agennix Incorporated | Lactoferrin in the reduction of pain |
US7034126B2 (en) | 2003-05-14 | 2006-04-25 | Agennix, Inc. | Lactoferrin in the treatment of diabetes mellitus |
CA2527904A1 (en) | 2003-06-06 | 2005-05-26 | Agennix Incorporated | Lactoferrin as an adjuvant in cancer vaccines |
US7183381B2 (en) | 2004-10-26 | 2007-02-27 | Agennix, Inc. | Composition of lactoferrin related peptides and uses thereof |
PL2643344T3 (en) | 2010-11-26 | 2017-09-29 | Evonik Röhm Gmbh | Human lactoferrin derived peptide for use as an antigen masking agent |
EP2481751A1 (en) * | 2011-01-26 | 2012-08-01 | PharmaSurgics in Sweden AB | Human lactoferrin derived peptides |
RU2488406C1 (en) * | 2012-02-16 | 2013-07-27 | Общество с ограниченной ответственностью "НТфарма" | Pharmaceutical composition for therapy of acute toxic conditions |
RU2687969C1 (en) * | 2018-03-02 | 2019-05-17 | Федеральное государственное бюджетное учреждение науки Институт биологии гена Российской академии наук | Antimicrobial agent |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0648955A (en) * | 1992-07-29 | 1994-02-22 | Morinaga Milk Ind Co Ltd | Activator for digestive tract cell |
RU2099065C1 (en) * | 1994-09-23 | 1997-12-20 | Московский научно-исследовательский онкологический институт им. П.А.Герцена МЗ РФ | Preparation and method for treating local complications occurring during conservative antitumoral treatment in oropharyngeal zone |
RU2088238C1 (en) * | 1995-02-28 | 1997-08-27 | Московский научно-исследовательский онкологический институт им.П.А.Герцена | Agent for rheumatic arthritis treatment |
EP0955058B1 (en) * | 1997-01-09 | 2004-05-26 | Morinaga Milk Industry Co., Ltd. | Lactoferrin tablets |
JP2001519815A (en) * | 1997-04-10 | 2001-10-23 | エイジェニックス・インコーポレイテッド | Use of lactoferrin in the treatment of allergen-induced disorders |
-
2000
- 2000-07-13 RU RU2000118424/14A patent/RU2165769C1/en active
-
2001
- 2001-07-09 WO PCT/RU2001/000276 patent/WO2002003910A2/en active Application Filing
- 2001-07-09 AU AU2001277824A patent/AU2001277824A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002003910A2 (en) | 2002-01-17 |
WO2002003910A3 (en) | 2002-06-20 |
RU2165769C1 (en) | 2001-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6497600A (en) | Peracid forming system, peracid forming composition, and methods for making and using | |
AU2002218909A1 (en) | Packet encrypton system and method | |
AU6397301A (en) | Synchronization method | |
AU2001249337A1 (en) | Network dma method | |
AU2001248279A1 (en) | New compounds, their preparation and use | |
AU2001292055A1 (en) | Colour system | |
AU2001289684A1 (en) | Glass-ceramics, process for their preparation and use | |
AUPQ970300A0 (en) | Advanced wireless network | |
AU2016701A (en) | Secure communications method | |
AU2002223690A1 (en) | Method for producing an organic solvent-free lycopene concentrate, the resulting concentrate and composition comprising said concentrate | |
AU2001279850A1 (en) | Method and arrangement for studsystem | |
AU2001277824A1 (en) | Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation | |
AU6594401A (en) | 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines | |
AU2002242996A1 (en) | Spiroisoquinoline compounds, methods for their preparation and intermediates | |
AU2000254308A1 (en) | Pyrazolopyrimidinone derivatives, process for their preparation and their use | |
AU4263501A (en) | Colour specification | |
AU2001237530A1 (en) | Method | |
AU2001234616A1 (en) | Vaccine composition, process and methods | |
AU2001266176A1 (en) | Methods | |
AU2002216479A1 (en) | Isolation method | |
AU2000267372A1 (en) | Polyoxyethylene-polyoxypropylene vitamin e and process for preparation thereof | |
AU2001266689A1 (en) | 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof | |
AU2002227966A1 (en) | Coniosetin and derivatives thereof, method for producing the same and use thereof | |
AU2001241636A1 (en) | Halotherapy method | |
AU2001288496A1 (en) | Receiver, and method |